{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T03:53:43Z","timestamp":1789098823197,"version":"build-2803163510"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,29]],"date-time":"2024-05-29T00:00:00Z","timestamp":1716940800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100012542","name":"Sichuan Province Science and Technology Support Program","doi-asserted-by":"publisher","award":["2023NSFSC0681"],"award-info":[{"award-number":["2023NSFSC0681"]}],"id":[{"id":"10.13039\/100012542","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012542","name":"Sichuan Province Science and Technology Support Program","doi-asserted-by":"publisher","award":["2022ZYD0092"],"award-info":[{"award-number":["2022ZYD0092"]}],"id":[{"id":"10.13039\/100012542","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81703922"],"award-info":[{"award-number":["81703922"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82374088"],"award-info":[{"award-number":["82374088"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81803931"],"award-info":[{"award-number":["81803931"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82274142"],"award-info":[{"award-number":["82274142"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.biopha.2024.116852","type":"journal-article","created":{"date-parts":[[2024,6,3]],"date-time":"2024-06-03T06:52:40Z","timestamp":1717397560000},"page":"116852","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Chemopreventive effects of atractylenolide-III on mammary tumorigenesis via activation of the Nrf2\/ARE pathway through autophagic degradation of Keap1"],"prefix":"10.1016","volume":"176","author":[{"given":"Fangyi","family":"Long","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pinghan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xudong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2024.116852_bib1","article-title":"The Global, Regional, and National Burden and Trends of Breast Cancer From 1990 to 2019: results from the global burden of disease study 2019","volume":"11","author":"Xu","year":"2021","journal-title":"Front Oncol."},{"key":"10.1016\/j.biopha.2024.116852_bib2","first-page":"209","article-title":"Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.biopha.2024.116852_bib3","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1038\/s41572-019-0111-2","article-title":"Breast cancer","volume":"5","author":"Harbeck","year":"2019","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.biopha.2024.116852_bib4","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1200\/JCO.18.01160","article-title":"Adjuvant Endocrine Therapy for Women With Hormone Receptor-Positive Breast Cancer: ASCO Clinical Practice Guideline Focused Update","volume":"37","author":"Burstein","year":"2019","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.biopha.2024.116852_bib5","unstructured":"National Comprehensive Cancer Network, NCCN Guidelines: Breast Cancer Risk Reduction. URL (https:\/\/www.nccn.org\/guidelines\/guidelines-detail?%20category=2&id=1420) (accessed 30 June 2021)."},{"key":"10.1016\/j.biopha.2024.116852_bib6","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1001\/jama.2019.11885","article-title":"Medication use to reduce risk of breast cancer: us preventive services task force recommendation statement","volume":"322","author":"Preventive Services Task Force","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.biopha.2024.116852_bib7","doi-asserted-by":"crossref","first-page":"4273","DOI":"10.1039\/D2FO00186A","article-title":"Dietary phytochemicals targeting Nrf2 for chemoprevention in breast cancer","volume":"13","author":"Wang","year":"2022","journal-title":"Food Funct."},{"key":"10.1016\/j.biopha.2024.116852_bib8","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.3390\/antiox10091455","article-title":"Role of phytochemicals in cancer chemoprevention: insights","volume":"10","author":"George","year":"2021","journal-title":"Antioxid. (Basel)"},{"key":"10.1016\/j.biopha.2024.116852_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.biotechadv.2018.11.011","article-title":"Dietary phytochemicals in colorectal cancer prevention and treatment: a focus on the molecular mechanisms involved","volume":"38","author":"Afrin","year":"2020","journal-title":"Biotechnol. Adv."},{"key":"10.1016\/j.biopha.2024.116852_bib10","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.semcancer.2021.05.016","article-title":"The intricacies of NRF2 regulation in cancer","volume":"76","author":"Schmidlin","year":"2021","journal-title":"Semin Cancer Biol."},{"key":"10.1016\/j.biopha.2024.116852_bib11","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.freeradbiomed.2021.06.031","article-title":"Role of chemopreventive phytochemicals in NRF2-mediated redox homeostasis in humans","volume":"172","author":"Chun","year":"2021","journal-title":"Free Radic. Biol. Med"},{"key":"10.1016\/j.biopha.2024.116852_bib12","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1002\/cam4.2101","article-title":"Nrf2 in cancers: a double-edged sword","volume":"8","author":"Wu","year":"2019","journal-title":"Cancer Med"},{"key":"10.1016\/j.biopha.2024.116852_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113699","article-title":"The antitumor properties of atractylenolides: molecular mechanisms and signaling pathways","volume":"155","author":"Jiang","year":"2022","journal-title":"Biomed. Pharm."},{"key":"10.1016\/j.biopha.2024.116852_bib14","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.7150\/ijbs.68873","article-title":"Atractylenolide III ameliorates Non-Alcoholic Fatty Liver Disease by activating Hepatic Adiponectin Receptor 1-Mediated AMPK Pathway","volume":"18","author":"Li","year":"2022","journal-title":"Int J. Biol. Sci."},{"key":"10.1016\/j.biopha.2024.116852_bib15","article-title":"Atractylenolide \u2162 Attenuates Angiogenesis in Gastric Precancerous Lesions Through the Downregulation of Delta-Like Ligand 4","volume":"13","author":"Gao","year":"2022","journal-title":"Front Pharm."},{"key":"10.1016\/j.biopha.2024.116852_bib16","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1097\/CAD.0000000000001136","article-title":"Atractylenolide \u2162 induces apoptosis by regulating the Bax\/Bcl-2 signaling pathway in human colorectal cancer HCT-116 Cells in vitro and in vivo","volume":"33","author":"Zhang","year":"2022","journal-title":"Anticancer Drugs"},{"key":"10.1016\/j.biopha.2024.116852_bib17","doi-asserted-by":"crossref","DOI":"10.1111\/jfbc.13582","article-title":"Atractylenolide \u2162 predisposes miR-195-5p\/FGFR1 signaling axis to exert tumor-suppressive functions in liver cancer","volume":"45","author":"Sheng","year":"2021","journal-title":"J. Food Biochem"},{"key":"10.1016\/j.biopha.2024.116852_bib18","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1080\/08923973.2020.1806871","article-title":"Atractylenolide \u2162 attenuates bleomycin-induced experimental pulmonary fibrosis and oxidative stress in rat model via Nrf2\/NQO1\/HO-1 pathway activation","volume":"42","author":"Huai","year":"2020","journal-title":"Immunopharmacol. Immunotoxicol."},{"key":"10.1016\/j.biopha.2024.116852_bib19","doi-asserted-by":"crossref","DOI":"10.1002\/cbdv.202001001","article-title":"Atractylenolide \u2162 Ameliorates TNBS-Induced Intestinal Inflammation in Mice by Reducing Oxidative Stress and Regulating Intestinal Flora","volume":"18","author":"Ren","year":"2021","journal-title":"Chem. Biodivers."},{"key":"10.1016\/j.biopha.2024.116852_bib20","doi-asserted-by":"crossref","DOI":"10.1530\/JME-22-0174","article-title":"RISING STARS: hormonal regulation of the breast cancer microenvironment","volume":"70","author":"Boyle","year":"2023","journal-title":"J. Mol. Endocrinol."},{"key":"10.1016\/j.biopha.2024.116852_bib21","first-page":"401","article-title":"N-nitrosomethylurea as mammary gland carcinogen in rats","volume":"54","author":"Gullino","year":"1975","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.biopha.2024.116852_bib22","first-page":"244","article-title":"Comparative study of human and rat mammary tumorigenesis","volume":"62","author":"Russo","year":"1990","journal-title":"Lab Invest"},{"key":"10.1016\/j.biopha.2024.116852_bib23","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1002\/ijc.22684","article-title":"Serial transplantation of NMU-induced rat mammary tumors: a model of human breast cancer progression","volume":"121","author":"Chan","year":"2007","journal-title":"Int J. Cancer"},{"key":"10.1016\/j.biopha.2024.116852_bib24","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0304-3835(01)00548-1","article-title":"Chemoprevention of NMU-induced rat mammary carcinoma with the combination of melatonin and 9-cis-retinoic acid","volume":"168","author":"Teplitzky","year":"2001","journal-title":"Cancer Lett."},{"key":"10.1016\/j.biopha.2024.116852_bib25","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.ccell.2018.03.022","article-title":"NRF2 and the Hallmarks of Cancer","volume":"34","author":"Rojo de la Vega","year":"2018","journal-title":"Cancer Cell"},{"key":"10.1016\/j.biopha.2024.116852_bib26","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.canlet.2013.08.014","article-title":"Molecular mechanisms underlying chronic inflammation-associated cancers","volume":"345","author":"Wu","year":"2014","journal-title":"Cancer Lett."},{"key":"10.1016\/j.biopha.2024.116852_bib27","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.cell.2010.01.025","article-title":"Immunity, inflammation, and cancer","volume":"140","author":"Grivennikov","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.biopha.2024.116852_bib28","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.gde.2009.11.004","article-title":"Inflammation and oncogenesis: a vicious connection","volume":"20","author":"Grivennikov","year":"2010","journal-title":"Curr. Opin. Genet Dev."},{"key":"10.1016\/j.biopha.2024.116852_bib29","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1084\/jem.20181739","article-title":"Modulating inflammation for cancer therapy","volume":"216","author":"Ritter","year":"2019","journal-title":"J. Exp. Med"},{"key":"10.1016\/j.biopha.2024.116852_bib30","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1016\/j.freeradbiomed.2010.09.006","article-title":"Oxidative stress, inflammation, and cancer: how are they linked? Free","volume":"49","author":"Reuter","year":"2010","journal-title":"Radic. Biol. Med"},{"key":"10.1016\/j.biopha.2024.116852_bib31","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.tips.2022.12.003","article-title":"Advances and challenges in therapeutic targeting of NRF2","volume":"44","author":"Dinkova-Kostova","year":"2023","journal-title":"Trends Pharm. Sci."},{"key":"10.1016\/j.biopha.2024.116852_bib32","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1002\/med.21396","article-title":"The Keap1-Nrf2-ARE pathway as a potential preventive and therapeutic target: an update","volume":"36","author":"Lu","year":"2016","journal-title":"Med Res Rev."},{"key":"10.1016\/j.biopha.2024.116852_bib33","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.bcp.2018.07.006","article-title":"Resveratrol represses estrogen-induced mammary carcinogenesis through NRF2-UGT1A8-estrogen metabolic axis activation","volume":"155","author":"Zhou","year":"2018","journal-title":"Biochem Pharm."},{"key":"10.1016\/j.biopha.2024.116852_bib34","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1002\/cbf.3309","article-title":"Screening active components of modified Xiaoyao powder as NRF2 agonists","volume":"35","author":"Yang","year":"2017","journal-title":"Cell Biochem Funct."},{"key":"10.1016\/j.biopha.2024.116852_bib35","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/mc.23266","article-title":"RNA-seq reveals novel cancer-selective and disease subtype-independent mechanistic targets of withaferin A in human breast cancer cells","volume":"60","author":"Hahm","year":"2021","journal-title":"Mol. Carcinog."},{"key":"10.1016\/j.biopha.2024.116852_bib36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11010-017-3091-0","article-title":"Allyl isothiocyanate, a potent chemopreventive agent targets AhR\/Nrf2 signaling pathway in chemically induced mammary carcinogenesis","volume":"437","author":"Rajakumar","year":"2018","journal-title":"Mol. Cell Biochem"},{"key":"10.1016\/j.biopha.2024.116852_bib37","doi-asserted-by":"crossref","DOI":"10.1002\/jbt.22779","article-title":"Betulin ameliorates 7,12-dimethylbenz(a)anthracene-induced rat mammary cancer by modulating MAPK and AhR\/Nrf-2 signaling pathway","volume":"35","author":"Zhang","year":"2021","journal-title":"J. Biochem Mol. Toxicol."},{"key":"10.1016\/j.biopha.2024.116852_bib38","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1007\/s12010-022-04266-z","article-title":"Regulatory components of oxidative stress and inflammation and their complex interplay in carcinogenesis","volume":"195","author":"Dharshini","year":"2023","journal-title":"Appl. Biochem Biotechnol."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332224007364?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332224007364?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T22:53:58Z","timestamp":1781650438000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332224007364"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":38,"alternative-id":["S0753332224007364"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2024.116852","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chemopreventive effects of atractylenolide-III on mammary tumorigenesis via activation of the Nrf2\/ARE pathway through autophagic degradation of Keap1","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2024.116852","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"116852"}}